Putnam Investments’s Novavax NVAX Stock Holding History

Putnam Investments’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$339K	Sell	70,712 -126,913	-64%	-$777K	﹤0.01%	1073
2023 Q3	$1.43M	Buy	+197,625	New	+$1.58M	﹤0.01%	784
2022 Q2	–	Sell	-48,536	Closed	-$3.58M	–	1189
2022 Q1	$3.58M	Buy	+48,536	New	+$4.33M	0.01%	697
2021 Q3	–	Sell	-81,200	Closed	-$17.2M	–	813
2021 Q2	$17.2M	Buy	+81,200	New	+$14.9M	0.03%	275
2016 Q3	–	Sell	-4,675	Closed	-$680K	–	1318
2016 Q2	$680K	Sell	4,675 -20	-0.4%	-$2.29K	﹤0.01%	1159
2016 Q1	$485K	Buy	4,695 +103	+2%	+$11K	﹤0.01%	1248
2015 Q4	$771K	Sell	4,592 -86	-2%	-$13.2K	﹤0.01%	1211
2015 Q3	$661K	Buy	+4,678	New	+$1.05M	﹤0.01%	1265

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Putnam Investments's NVAX Position: Q4 2023 in Review

Putnam Investments reduced its Novavax (NVAX) stake by 64% in Q4 2023, selling an estimated $777K and leaving 70,712 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Putnam Investments first reported a position in NVAX in Q3 2015 and has held it in 8 quarters since. The position peaked at $17.2M in Q2 2021. 200 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

Putnam Investments held 70,712 shares of Novavax worth $339K as of Q4 2023.
Putnam Investments sold 126,913 Novavax shares in Q4 2023, an estimated $777K.
Novavax made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1073 holding.
Putnam Investments first reported a position in Novavax in Q3 2015 and has held it in 8 quarters since.
Putnam Investments's Novavax position peaked at $17.2M in Q2 2021.
200 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.